/Investor DB

Enterprise Ireland — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Precision Sports Technologykinetikiq.cominNov 2024✓ verified

KinetikIQ builds AI-powered, markerless 3D motion capture software that runs on an iPhone or iPad to measure joint angles and biomechanical metrics without wearables or specialized hardware.

AI & Machine LearningDigital HealthSports TechGalway, IE

Emma Meehan(Founder and CEO)Thomas Gerald Meehan(Executive Officer, Director)

Lativelative.ioin𝕏Jan 2024 · $3M

Lative is an AI-native platform for go-to-market (GTM) planning and decision intelligence that unifies sales strategy with execution by connecting marketing intelligence to sales operations.

AI & Machine LearningSaaS

Laura Tortosa Sancho(Founder)Werner Schmidt(Founder)

Co-investorsAct Venture CapitalACT Venture CapitalSenovoElkstone Capital PartnersShuttle FundWestWave Capital

Legitifylegitify.euin𝕏Mar 2024

Legitify is an online notarization service that lets professionals get documents notarized remotely, including for use cases such as KYB verification.

FintechLegalTechSaaS

Ricardo Cosme(Chief Technology Officer)in

Co-investorsAlchemist AcceleratorAntler

Nua Surgicalnuasurgical.comin𝕏Dec 2024

NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.

FemTechHealthtechMedical DevicesGalway, IE

Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)

Co-investorsCatalytic Impact FoundationTMC Venture FundEQT Life Sciences

Vertigeniusvertigenius.comMay 2024

Vertigenius develops software for vestibular rehabilitation, combining a clinician portal, patient app, and wearable head sensor to deliver and remotely monitor treatment for patients with vertigo, dizziness, and imbalance.

Digital HealthHealthtechMedical Devices

Dara Meldrumin

Co-investorsAtlantic Bridge Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.